Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.59
-36.01 (-3.82%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
88
89
Next >
Eli Lilly Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 06, 2024
Eli Lilly and Company (NYSE: LLY) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024.
Via
Benzinga
Markets Take A Powder; PLTR, NXPI Beat In Q4
February 06, 2024
We finished the normal trading session on the first day of a new trading week the same way we began it — reluctant to drag a stock market higher amid all-time high ranges on the Dow and S&P 500,...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Palantir, Nvidia, Eli Lilly, Symbotic, Tesla: Why These 5 Stocks Are On Investors' Radars Today
February 05, 2024
U.S. stocks traded lower at the end of trading on Monday with the Dow Jones Industrial Average declining 0.7% to 38,380.12.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Healthcare And Life Science Funds And ETFs Performance 2023-2024
February 05, 2024
Healthcare stocks usually provide a defensive posture to a stock portfolio.
Via
Talk Markets
Topics
ETFs
3 High-Octane Growth Stocks Not Slowing Down Any Time Soon
February 05, 2024
These high-octane growth stocks provide the kind of upside long-term investors should want from higher-risk bets.
Via
InvestorPlace
In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry
February 05, 2024
Via
Benzinga
Is It Too Late to Buy Eli Lilly Stock?
February 05, 2024
Growth may slow, and its valuation is looking precarious.
Via
The Motley Fool
Market Whales and Their Recent Bets on LLY Options
February 01, 2024
Via
Benzinga
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.
Via
InvestorPlace
Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record
February 05, 2024
Amgen is looking to rival Eli Lilly and Novo Nordisk in weight-loss drugs.
Via
Investor's Business Daily
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
What's Going On With Eli Lilly Stock Today?
February 05, 2024
Eli Lilly's stock surge, driven by the upcoming Q4 2023 results and the impact of FDA-approved weight-loss drug Zepbound.
Via
Benzinga
Novo Nordisk To Up Production Capacity As Parent Buys Catalent
February 05, 2024
NVO stock rose after Novo Nordisk's parent, Novo Holdings, said it has agreed to buy contract manufacturer Catalent for $11.5 billion in cash.
Via
Investor's Business Daily
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
February 05, 2024
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Weight Loss Drug's New Entrant: Amgen To Compete With Novo Nordisk, Eli Lilly, As Investigational Weight Loss Drug Shows Encouraging Early Data
February 05, 2024
Amgen's AMG 133 data. Promising results in obesity drug trials, including significant weight loss and improved metabolic markers.
Via
Benzinga
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q4 Earnings Report
February 05, 2024
Eli Lilly and Company (NYSE: LLY) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024.
Via
Benzinga
After a 90% Gain, Is It Too Late to Buy Eli Lilly?
February 04, 2024
Its drug tirzepatide showed top efficacy as a weight-loss treatment according to the latest real-world data.
Via
The Motley Fool
7 Mutual Funds That Will Outperform in Any Market
February 03, 2024
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds.
Via
InvestorPlace
SPDR ETF Report For Friday, February 2
February 03, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Friday, February 2.
Via
Talk Markets
Topics
ETFs
3 Pharma Stocks to Sell in February Before They Crash and Burn
February 02, 2024
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.
Via
InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
What's Going On With Eli Lilly Stock Today?
February 02, 2024
Eli Lilly reveals Q4 2023 results on Feb 6. Analysts anticipate $2.19 EPS, $8.932 billion in sales. Explore recent developments and FDA inspection.
Via
Benzinga
Exposures
Product Safety
The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone
February 01, 2024
Becoming a trillion-dollar milestone stock is more than just having a title. Rather, it indicates market dominance in the industry.
Via
InvestorPlace
Eli Lilly To Report Q4 Earnings: What's In The Cards?
February 01, 2024
We expect Eli Lilly & Company to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, before the market open.
Via
Talk Markets
Why Eli Lilly Stock Topped the Market Today
January 31, 2024
One of its more recently approved drugs will be launched into a white-hot market.
Via
The Motley Fool
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024
January 31, 2024
Biotech stocks are warming up in January and look to continue upward in 2024 as the economy improves. Here are three to check out.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares
January 31, 2024
Eli Lilly to report strong Q4 earnings thanks to successful diabetes treatments, while rivals like Novo Nordisk and Pfizer are also vying for a share of the weight-loss market.
Via
Benzinga
Elliott Wave Technical Analysis: Eli Lilly & Co. - Wednesday, Jan. 31
January 31, 2024
Looking for further upside into wave {v} as we seem to have successfully broken the previous Elliott Wave triangle in wave {iv}.
Via
Talk Markets
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
Tech Giants' Market Concentration Echoes Dot-Com Bubble Peak, Analysts Warn
January 30, 2024
Explore JPMorgan's analysis drawing parallels between today's US equity market and the dot-com bubble, highlighting the significant concentration of top stocks and sector dominance in the MSCI USA...
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
88
89
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.